Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CG Oncology Q1 EPS $(0.45) Misses $(0.41) Estimate, Sales $52.00K Miss $212.75K Estimate

Author: Benzinga Newsdesk | May 13, 2025 07:06am
CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.41) by 9.76 percent. This is a 25 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $52.00 thousand which missed the analyst consensus estimate of $212.75 thousand by 75.56 percent. This is a 90.17 percent decrease over sales of $529.00 thousand the same period last year.

Posted In: CGON


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist